Market closedNon-fractional

10x Genomics/TXG

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About 10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Ticker

TXG

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Pleasanton, United States

Employees

1,259

10x Genomics Metrics

BasicAdvanced
$2.3B
Market cap
-
P/E ratio
-$2.24
EPS
1.89
Beta
-
Dividend rate
$2.3B
1.89
5.215
4.259
11.275
12.823
-13,490.60%
-13.06%
-34.75%
3.582
3.15
3.24
-30.298
16.64%
47.00%
23.41%
-24.13%

What the Analysts think about 10x Genomics

Analyst Ratings

Majority rating from 17 analysts.
Buy

10x Genomics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-42.48% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$141M
-23.33%
Net income
-$60M
22.49%
Profit margin
-42.48%
59.76%

10x Genomics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 0.08%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.53
-$0.79
-$0.41
-$0.50
-
Expected
-$0.40
-$0.46
-$0.36
-$0.50
-$0.48
Surprise
31.31%
71.91%
14.40%
-0.08%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for 10x Genomics stock?

10x Genomics (TXG) has a market cap of $2.3B as of July 25, 2024.

What is the P/E ratio for 10x Genomics stock?

The price to earnings (P/E) ratio for 10x Genomics (TXG) stock is 0 as of July 25, 2024.

Does 10x Genomics stock pay dividends?

No, 10x Genomics (TXG) stock does not pay dividends to its shareholders as of July 25, 2024.

When is the next 10x Genomics dividend payment date?

10x Genomics (TXG) stock does not pay dividends to its shareholders.

What is the beta indicator for 10x Genomics?

10x Genomics (TXG) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell 10x Genomics stock

Buy or sell 10x Genomics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing